BAIN CAPITAL INVESTORS LLC purchased 47.0% of their position (8.40M shares) of KAILERA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $134.38M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/20/2026ACC: 0001193125-26-164417
10% Owner
Since Apr 2026
+8.40M
Net shares
Net buyer
$134.38M
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
26.26M acquired · 17.86M disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+17.86M
Price / share
—
Trade value
—
% of position
New position
4/20/2026
0.00→17.86M
Common Stock
Indirect
Shares
+8.40M
Price / share
$16.00
Trade value
$134.38M
% of position
47.0%
4/20/2026
17.86M→26.26M
Total
Net shares
+26.26M
Net value
$134.38M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/20/2026 | C · Conversion | +17.86M | — | — | New position | 0.00 | 17.86M |
| Common Stock Indirect | 4/20/2026 | P · Purchase | +8.40M | $16.00 | $134.38M | 47.0% | 17.86M | 26.26M |
| Total | +26.26M | $134.38M | ||||||
Derivative Transactions1
Series B Preferred Stock
Indirect
Converts to
Common Stock
17.86M shares
Shares
−17.86M
Strike price
Held after
0.00
Exercisable
—
4/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Indirect | Common Stock17.86M shares | 4/20/2026 | C · Conversion | −17.86M | — | 0.00 |